NCT02824393View on ClinicalTrials.gov

Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

May 15, 2018

Study Completion Date

July 15, 2018

Conditions
UrticariaAutoimmune DiseasesImmune System DiseasesSkin Diseases
Interventions
BIOLOGICAL

Autologous mesenchymal stem cell

Intravenous infusion of ex vivo cultured adipose tissue derived autologous mesenchymal stem cells, twice at two week intervals in total 1x10/6 cells/kg.

Trial Locations (1)

Unknown

Celal Bayar University, Medical School, Manisa

All Listed Sponsors
collaborator

The Scientific and Technological Research Council of Turkey

OTHER

collaborator

Acıbadem Labcell

OTHER

lead

Celal Bayar University

OTHER

NCT02824393 - Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria | Biotech Hunter | Biotech Hunter